Oxford Events, the new replacement for OxTalks, will launch on 16th March. The two-week OxTalks freeze period starts on Monday 2nd March. During this time, there will be no facility to publish or edit events. The existing OxTalks site will remain available to view during this period. Once Oxford Events launches, you will need a Halo login to submit events. Full details are available on the Staff Gateway.
Apollo Therapeutics is a portfolio biopharmaceutical company based in the UK and USA. They translate breakthroughs in biology and basic medical research into innovative new medicines. With over 20 active therapeutic programs, six of which are in development, they are building a large, diversified portfolio of novel therapeutics with uncorrelated risk. Apollo Therapeutics and the University of Oxford have entered into drug discovery and development collaboration
The seminar will be followed by lunch and and networking.
